In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
Moscow with a population of 12 million looks a bit empty. The restaurant is not as crowded as bef
Now only seven days are left for the World Cup to be held in India. 10 teams will participate in
In the meeting of the State Advisory Committee of the State Electricity Regulatory Commission on
The command of Twitter has now come into the hands of Elon Musk. After this, Elon Musk sacked sev
What is the meaning of what Jaishankar said in relations with China?
Indian External Affairs Minister S Jaishankar said on Saturday at the Munich Security Conference
Imran Khan's MP arrested in Pakistan, tweeted against military officers
Pakistan's investigative agency FIA has arrested Imran Khan's PTI MP Azam Swati in the National A
Russian military action in Ukraine has worsened the situation. Meanwhile, the plane has reached D
Former US President Donald Trump seems to be implicated in the riots that took place on January 6
Salaar OTT Release: KGF director Prashant Neel's film Salaar broke records at the box office. The
DRDO's anti-corona drug 2DG was released on Monday for Emergency Use. Now, these can be given to
